Subgroup‐specific dose finding in phase I clinical trials based on time to toxicity allowing adaptive subgroup combination (Q121634)

From MaRDI portal
Revision as of 16:44, 25 April 2024 by Import240425040427 (talk | contribs) (Added link to MaRDI item.)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
scientific article
Language Label Description Also known as
English
Subgroup‐specific dose finding in phase I clinical trials based on time to toxicity allowing adaptive subgroup combination
scientific article

    Statements

    DOI
    10.1002/pst.1891
    0 references
    volume
    17
    0 references
    issue
    6
    0 references
    page(s)
    734-749
    0 references
    publication date
    15 August 2018
    0 references
    author
    Andrew G. Chapple
    0 references
    Peter F Thall
    0 references
    Wikidata QID
    Q90971711
    0 references
     
    Retrieved from "https://portal.mardi4nfdi.de/w/index.php?title=Item:Q121634&oldid=33786193"
    Powered by MediaWiki